2022 Guide to Patient Support Services

AVEO Pharmaceuticals

AVEO ACE

833-368-4832

AVEO Pharmaceuticals offers AVEO ACE, a comprehensive program dedicated to providing personalized support to patients and their caregivers while taking Fotivda treatment (Table).

AVEO ACE

AVEO ACE Program Specialists are committed to helping patients access Fotivda, regardless of insurance circumstance. They can provide support, including insurance coverage support and financial assistance, as well as ongoing education.

Insurance Coverage Support

Insurance coverage support through AVEO ACE includes benefit investigation, prior authorization navigation, appeals information, the Quick Start Program, and the Bridge Program. The Quick Start Program provides free Fotivda to eligible patients who experience a payer decision delay of 5 business days or more. The Bridge Program provides free Fotivda to eligible patients who experience coverage interruptions while already on treatment. Patients may be eligible for the Quick Start or Bridge programs if:

  • Coverage for Fotivda cannot be verified within 5 business days, and/or
  • There are other circumstances present, including, but not limited to, patient safety.

Click here to learn more or to enroll your patient, or call 833-368-4832.

AVEO ACE Co-pay Assistance Program

Patients who have commercial or private insurance may be eligible to enroll in the AVEO ACE Co-pay Assistance Program if they:

  • Are a resident of the United States or a United States territory
  • Have a commercial insurance plan
  • Are not enrolled in any government-funded insurance program such as Medicare or Medicaid.

Click here to enroll your patient online.

AVEO ACE Patient Assistance Program

Patients who are uninsured or underinsured may access Fotivda through the AVEO ACE Patient Assistance Program if they:

  • Are a resident of the United States or a United States territory
  • Are uninsured or underinsured
  • Meet financial eligibility requirements.

Click here to enroll your patient online.

TABLE AVEO Pharmaceuticals Oncology Drug

Drug
Indications
Patient support programs

Drug
Fotivda (tivozanib) capsules, for oral use
Indications
Treatment of adult patients with relapsed or refractory advanced renal-cell carcinoma following 2 or more prior systemic therapies
Patient support programs

Report Broken Links

Have you encountered a problem with a URL (link) on this page not loading correctly or is displaying an error message?

Help us fix it! Report broken links here.

Report Broken Links

Report Broken Links

*OPM Webpage
Please copy the URL (link) of the OPM webpage you are currently on.
*Broken Link
Please copy the URL (link) to the external webpage that is not displaying content correctly.
Errors include, but are not limited to:
  • "This site can’t be reached"
  • "Hmm. We’re having trouble finding that site."
  • "Hmmm… can't reach this page"
  • "404 Error: Page not found"
Comments
(Optional)